We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLF:NYSESun Life Financial Inc. Analysis

Data as of 2026-05-01 - not real-time

$72.08

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Sun Life Financial is riding strong bullish momentum, with price comfortably above its short‑term and medium‑term averages and a bullish MACD signal reinforcing the upward trend. Volume is on the rise, supporting the price advance, while the RSI sits in the overbought zone, suggesting that a short‑term pull‑back could be imminent. Fundamentally, the company posts solid revenue growth and healthy profit margins, and its price‑earnings multiple is modest relative to industry peers, indicating a valuation discount. The dividend yield is attractive and the payout ratio remains comfortable, pointing to sustainable income for shareholders. A discounted cash‑flow model places intrinsic value well above the current price, highlighting a sizeable undervaluation. The balance sheet shows ample cash and a manageable debt profile, and the strategic shift toward fee‑based asset management is expected to boost earnings and return on equity. Upcoming quarterly results will be a key catalyst to confirm the momentum and earnings trajectory. Overall, the stock combines technical strength with fundamental upside and a reliable dividend stream.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD confirming trend
  • Increasing volume supporting price rise
  • RSI in overbought territory suggesting caution

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant undervaluation relative to DCF
  • Fee‑based asset management transformation driving earnings growth
  • Attractive and sustainable dividend yield

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Low beta and modest volatility indicating defensive profile
  • Global diversification reducing concentration risk
  • Strong cash position and disciplined capital management

Key Metrics & Analysis

Financial Health

Revenue Growth4.70%
Profit Margin10.18%
P/E Ratio16.0
ROE13.90%
ROA0.85%
Debt/Equity90.27
P/B Ratio2.4
Op. Cash Flow$2.8B
Free Cash Flow$-4225999872
Industry P/E17.6

Technical Analysis

TrendBullish
RSI72.7
Support$62.08
Resistance$72.12
MA 20$68.34
MA 50$65.65
MA 200$62.07
MACDBullish
VolumeIncreasing
Fear & Greed Index90.96

Valuation

Fair Value$196.18
Target Price$67.33
Upside/Downside-6.58%
GradeUndervalued
TypeBlend
Dividend Yield3.67%

Risk Assessment

Beta0.39
Volatility18.80%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.